PRESS

 

PRESS CONFERENCE SCHEDULE

Embargo Policy for TCT 2019

Please note that press conference presentations of late-breaking trials and science at TCT are held prior to the Main Arena presentations as a courtesy to the media. Embargoes do not lift until the start time of each individual Main Arena presentation, as listed in the TCT agenda. All embargo times are listed in Pacific Time (PT). This schedule is subject to change.

*Please note: The press conference for Sunday trials will be held on the morning of Saturday, September 28th.

Thursday, September 26, 2019

8:00 AM – 9:45 AM
Moderator: Ori Ben-Yehuda, MD
Discussants: Davide Capodanno, MD, PhD; Robert A. Harrington, MD; Vijay Kunadian, MD, MBBS; Marco Valgimigli, MD, PhD 

8:00 AM
TWILIGHT: A Randomized Trial of Ticagrelor Monotherapy vs. Ticagrelor-Plus-Aspirin Beginning at 3 Months in High-Risk Patients Undergoing PCI
Roxana Mehran, MD
Embargo Lift Time: 9/26/19; 10:30 AM PT

8:15 AM
IDEAL-LM: A Randomized Trial of a Bioabsorbable Polymer DES With 4-Month DAPT vs. a Durable Polymer DES With 12-Month DAPT in Patients With Left Main Coronary Artery Disease
Robert-Jan Van Geuns, MD, PhD
Embargo Lift Time: 9/26/19; 11:10 AM PT

8:30 AM
TWILIGHT Thrombogenicity Substudy: Impact of Ticagrelor Alone vs. Ticagrelor Plus Aspirin on Ex-Vivo Blood Thrombogenicity in High-Risk Patients Undergoing PCI
Usman Baber, MD
Embargo Lift Time: 9/26/19; 1:00 PM PT 

8:45 AM
Onyx ONE: A Randomized Trial of a Durable-Polymer Drug-Eluting Stent vs. a Polymer-Free Drug-Coated Stent in Patients at High Risk of Bleeding Treated With 1-Month DAPT
Stephan Windecker, MD
Embargo Lift Time: 9/26/19; 10:50 AM PT

9:00 AM
MODEL U-SES: A Single-Arm Study of 3-Month DAPT in Patients Treated With a Bioabsorbable Polymer-Based Sirolimus-Eluting Stent
Ken Kozuma, MD, PhD
Embargo Lift Time: 9/26/19; 12:30 PM PT   

9:15 AM
AUGUSTUS ACS: A 2x2 Factorial Randomized Trial of Apixaban vs. Warfarin and Aspirin vs. Placebo in Patients With Atrial Fibrillation and an Acute Coronary Syndrome
Stephan Windecker, MD
Embargo Lift Time: 9/26/19; 12:45 PM PT    

9:30 AM
EVOLVE Short DAPT: A Single-Arm Study of 3-Month DAPT in Patients at High Bleeding Risk Treated With a Bioabsorbable Polymer-Based Everolimus-Eluting Stent
Ajay J. Kirtane, MD, SM
Embargo Lift Time: 9/26/19; 12:15 PM PT

Friday, September 27, 2019

8:00 AM – 9:45 AM
Moderator: Ajay J. Kirtane, MD, SM
Discussants: Robert O. Bonow, MD, MS; Samir R. Kapadia, MD; Michael J. Mack, MD; Pinak B. Shah, MD 

8:00 AM
SCOPE I: A Randomized Trial of the ACURATE Neo vs. the SAPIEN 3 Bioprosthesis in Patients With Severe Aortic Stenosis
Jonas Lanz, MD, MSc
Embargo Lift Time: 9/27/19; 10:30 AM PT

8:15 AM
PORTICO: A Randomized Trial of Portico vs. Commercially Available Transcatheter Aortic Valves in Patients With Severe Aortic Stenosis
Gregory P. Fontana, MD
Embargo Lift Time: 9/27/19; 10:50 AM PT  

8:30 AM
PARTNER 3 Low-Risk Computed Tomography Substudy: Subclinical Leaflet Thrombosis in Transcatheter and Surgical Bioprosthetic Valves
Raj Makkar, MD
Embargo Lift Time: 9/27/19; 11:10 AM PT

8:45 AM
Mitral Valve-in-Valve: 1-Year Outcomes of Transcatheter Mitral Valve Replacement for Degenerated Mitral Bioprotheses
Mayra Guerrero, MD
Embargo Lift Time: 9/27/19; 12:15 PM PT

9:00 AM
STS/ACC TVT Registry: MitraClip Operator Volume-Outcome Relationship in the United States
Adnan K. Chhatriwalla, MD
Embargo Lift Time: 9/27/19; 12:30 PM PT

9:15 AM
STS Registry: Mitral Valve Surgery Institutional Volume-Outcome Relationship in the United States
Vinay Badhwar, MD
Embargo Lift Time: 9/27/19; 12:45 PM PT

9:30 AM
A Propensity Score-Matched Analysis of Transcatheter Tricuspid Valve Treatment vs. Medical Treatment in Patients With Severe Tricuspid Regurgitation
Maurizio Taramasso, MD, PhD
Embargo Lift Time: 9/27/19; 1:00 PM PT

Saturday, September 28, 2019

7:00 AM – 8:45 AM
Moderator: Roxana Mehran, MD
Discussants: David H. Adams, MD; Martine Gilard, MD, PhD; Samir R. Kapadia, MD; Marie-Claude Morice, MD

7:00 AM
EURO-CTO: 3-Year Outcomes From a Randomized Trial of PCI vs. Medical Therapy in Patients With Chronic Total Coronary Occlusions
Gerald S. Werner, MD
Embargo Lift Time: 9/28/19; 12:30 PM PT  

7:15 AM
PARTNER 2A: 5-Year Outcomes From a Randomized Trial of Transcatheter vs. Surgical Aortic Valve Replacement in Intermediate-Risk Patients With Severe Aortic Stenosis
Vinod H. Thourani, MD
Embargo Lift Time: 9/28/19; 10:50 AM PT

7:30 AM
MODERATO II: A Double-Blind Randomized Trial of Cardiac Neuromodulation Therapy in Patients With Hypertension
Karl-Heinz Kuck, MD, PhD
Embargo Lift Time: 9/28/19; 12:45 PM PT  

7:45 AM
COMPLETE Timing Substudy: A Randomized Trial of Complete Staged Revascularization vs. Infarct Artery PCI Alone in Patients With Acute Myocardial Infarction and Multivessel Disease — Importance of Revascularization Timing
David A. Wood, MD
Embargo Lift Time: 9/28/19; 12:15 PM PT   

8:00 AM
COAPT: 3-Year Outcomes From a Randomized Trial of the MitraClip in Patients With Heart Failure and Severe Secondary Mitral Regurgitation
Michael J. Mack, MD
Embargo Lift Time: 9/28/19; 10:30 AM PT

8:15 AM
EXCEL: 5-Year Outcomes From a Randomized Trial of PCI vs. CABG in Patients With Left Main Coronary Artery Disease
Gregg W. Stone, MD
Embargo Lift Time: 9/28/19; 11:10 AM PT

8:30 AM
LEVANT: 5-Year Outcomes From Three Randomized Trials of Percutaneous Angioplasty With vs. Without a Drug-Coated Balloon in Patients With Femoropopliteal Arterial Disease
Kenneth Ouriel, MD, MBA
Embargo Lift Time: 9/28/19; 1:00 PM PT   

Saturday, September 28, 2019*

*Please note: The press conference for Sunday trials will be held on Saturday, September 28th.
8:45 AM – 10:30 AM  
Moderator: Juan F. Granada, MD
Discussants: Suzanne V. Arnold, MD, MHA; Sripal Bangalore, MD, MHA; Donald Cutlip, MD; Gary S. Mintz, MD

8:45 AM
COAPT: Cost-Effectiveness Analysis From a Randomized Trial of the MitraClip in Patients With Heart Failure and Severe Secondary Mitral Regurgitation
Suzanne J. Baron, MD, MSc
Embargo Lift Time: 9/29/19; 8:45 AM PT  

9:00 AM
PARTNER 3: Health Status Outcomes From a Randomized Trial of Transcatheter vs. Surgical Aortic Valve Replacement in Patients With Severe Aortic Stenosis at Low Surgical Risk
Suzanne J. Baron, MD, MSc
Embargo Lift Time: 9/29/19; 9:05 AM PT   

9:15 AM
REMEDIAL III: A Randomized Trial of Urine Flow Rate-Guided vs. LVEDP-Guided Hydration in Patients at High Risk for Contrast Nephropathy
Carlo Briguori, MD, PhD
Embargo Lift Time: 9/29/19; 9:25 AM PT

9:30 AM
FORZA: A Randomized Trial of Fractional Flow Reserve vs Optical Coherence Tomography to Guide Revascularization of Intermediate Coronary Stenoses
Francesco Burzotta, MD, PhD
Embargo Lift Time: 9/29/19; 11:30 AM PT

9:45 AM
BLADE-PCI: A Randomized Trial of Liposomal Alendronate in Patients With Diabetes Undergoing PCI
Philippe Généreux, MD
Embargo Lift Time: 9/29/19; 11:15 AM PT

10:00 AM
BIODEGRADE: A Large-Scale Randomized Trial of a Thin-Strut Bioabsorbable Polymer-Based DES vs. a Thick-Strut Bioabsorbable Polymer-Based DES in an All-Comers Population With Coronary Artery Disease
In-Ho Chae, MD, PhD
Embargo Lift Time: 9/29/19; 11:00 AM PT

10:15 AM
IVUS-XPL: 5-Year Outcomes From a Randomized Trial of Intravascular Ultrasound-Guided vs. Angiography-Guided PCI of Long Coronary Lesions
Myeong-Ki Hong, MD, PhD
Embargo Lift Time: 9/29/19; 11:45 AM PT